The biologic era of childhood medulloblastoma and clues to novel therapies
S Khatua, W Zaky - Future oncology, 2014 - Taylor & Francis
Currently, the treatment of childhood medulloblastoma (MB) is tailored to risk groups defined
by clinical parameters. Growing evidence of tumoral heterogeneity is apparent as response …
by clinical parameters. Growing evidence of tumoral heterogeneity is apparent as response …
Genome network medicine: innovation to overcome huge challenges in cancer therapy
DH Roukos - Wiley Interdisciplinary Reviews: Systems Biology …, 2014 - Wiley Online Library
The post‐ENCODE era shapes now a new biomedical research direction for understanding
transcriptional and signaling networks driving gene expression and core cellular processes …
transcriptional and signaling networks driving gene expression and core cellular processes …
A comprehensive multicenter comparison of whole genome sequencing pipelines using a uniform tumor-normal sample pair
As next-generation sequencing becomes a clinical tool, a full understanding of the variables
affecting sequencing analysis output is required. Through the International Cancer Genome …
affecting sequencing analysis output is required. Through the International Cancer Genome …
Nicotine induces alteration of H3K27 demethylase UTX in kidney cancer cell
X Guo, X Li, Y Wang, Z Tian… - Human & experimental …, 2014 - journals.sagepub.com
Cigarette smoking is one of the most important risk factors for kidney cancer, but the
molecular mechanism is poorly understood. To examine the expression change of histone …
molecular mechanism is poorly understood. To examine the expression change of histone …
[HTML][HTML] When deletions gain functions: commandeering epigenetic mechanisms
Recurrent chromosomal deletions in cancer are typically thought to harbor tumor
suppressors. In a recent publication in Nature, Northcott and colleagues identify a novel …
suppressors. In a recent publication in Nature, Northcott and colleagues identify a novel …
Epigenetic reprogramming in cancer
Cancer is by and large caused by a combination of genetic lesions and obstructed gene
expression patterns that put afflicted cells in a growth advantage. Recent research has …
expression patterns that put afflicted cells in a growth advantage. Recent research has …
[HTML][HTML] Clinic-pathological description of three paediatric medulloblastoma cases with MLL2/3 gene mutations
GY Lopez, GA Grant, HE Fuchs, LG Leithe… - Neuropathology and …, 2014 - ncbi.nlm.nih.gov
Medulloblastoma is the most common paediatric malignant tumour. To identify altered
genetic events in a comprehensive manner, we recently performed exome sequencing of a …
genetic events in a comprehensive manner, we recently performed exome sequencing of a …
A comprehensive assessment of somatic mutation calling in cancer genomes
TS Alioto, S Derdak, TA Beck, PC Boutros, L Bower… - bioRxiv, 2014 - biorxiv.org
The emergence of next generation DNA sequencing technology is enabling high-resolution
cancer genome analysis. Large-scale projects like the International Cancer Genome …
cancer genome analysis. Large-scale projects like the International Cancer Genome …
癌症基因组测序方案制定的研究进展
安云鹤, 李宝明, 李越, 尹玲, 曲俊杰… - 中国生物工程 …, 2014 - manu60.magtech.com.cn
癌症的基因组测序对于癌症的预防, 诊断, 预后, 治疗以及基础生物学研究都有巨大的潜在的应用
价值, 正是由于其方向广泛, 所以基因组测序的方案制定对于实现特定的研究目标 …
价值, 正是由于其方向广泛, 所以基因组测序的方案制定对于实现特定的研究目标 …